{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T05:07:38Z","timestamp":1768626458736,"version":"3.49.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.pnpbp.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T01:09:47Z","timestamp":1472173787000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia"],"prefix":"10.1016","volume":"72","author":[{"given":"Joshua","family":"Lister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Andreazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushra","family":"Navaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia S.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasika","family":"Nesarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 N.","family":"Nobrega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2016.08.010_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(01)00393-X","article-title":"Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins","volume":"306","author":"Abuja","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajp.2013.12.010","article-title":"Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia","volume":"9","author":"Achalia","year":"2014","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0015","first-page":"1953","article-title":"Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics","volume":"10","author":"Adam","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0091-3057(99)00118-5","article-title":"Coenzyme Q10 does not prevent oral dyskinesias induced by long-term haloperidol treatment of rats","volume":"64","author":"Andreassen","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0025","doi-asserted-by":"crossref","first-page":"2930434","DOI":"10.1155\/2016\/2930434","article-title":"Oxidative stress markers in sputum","volume":"2016","author":"Antus","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0030","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s00213-016-4324-8","article-title":"Atypical antipsychotics and effects on feeding: from mice to men","volume":"233","author":"Benarroch","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1212\/WNL.0b013e31829d86b6","article-title":"Evidence-based guideline: treatment of tardive syndromes: report of the guideline development subcommittee of the American Academy of Neurology","volume":"81","author":"Bhidayasiri","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"Suppl. 4","key":"10.1016\/j.pnpbp.2016.08.010_bb0045","first-page":"5","article-title":"Tardive dyskinesia: pathophysiology and animal models","volume":"61","author":"Casey","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/bdd.2510130106","article-title":"Linear pharmacokinetics of haloperidol in the rat","volume":"13","author":"Cheng","year":"1992","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0055","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/nu6041424","article-title":"The effects of alpha-tocopherol on bone: a double-edged sword?","volume":"6","author":"Chin","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0060","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.3390\/nu6083214","article-title":"Vitamin E supplementation in chemical colorectal carcinogenesis: a two-edged knife","volume":"6","author":"Cohen","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2016.00024","article-title":"Antioxidant supplementation in the treatment of aging-associated diseases","volume":"7","author":"Conti","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/YCO.0b013e3282f53132","article-title":"Tardive dyskinesia and new antipsychotics","volume":"21","author":"Correll","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies","volume":"161","author":"Correll","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0080","first-page":"389","article-title":"Neurobiological basis of dyskinetic effects induced by antipsychotics: the contribution of animal models","volume":"20","author":"Creed","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tem.2012.05.008","article-title":"Protein carbonylation and metabolic control systems","volume":"23","author":"Curtis","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00213-003-1466-2","article-title":"Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal","volume":"169","author":"De Souza","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0095","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/syn.20851","article-title":"Antipsychotic-induced DRD2 upregulation and its prevention by alpha-lipoic acid in SH-SY5Y neuroblastoma cells","volume":"65","author":"Deslauriers","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0100","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1176\/ps.2008.59.5.507","article-title":"Who are the new users of antipsychotic medications?","volume":"59","author":"Domino","year":"2008","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s002130050095","article-title":"Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol","volume":"127","author":"Egan","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.pbb.2005.05.001","article-title":"High fat diet increases the incidence of orofacial dyskinesia and oxidative stress in specific brain regions of rats","volume":"81","author":"Fachinetto","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0115","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.pnpbp.2007.06.028","article-title":"Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter","volume":"31","author":"Fachinetto","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00213-007-0831-y","article-title":"Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats","volume":"194","author":"Fachinetto","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0125","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1517\/14656560903386292","article-title":"Tetrabenazine","volume":"10","author":"Fasano","year":"2009","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0130","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.3390\/ijms11114631","article-title":"Isoprostanes-biomarkers of lipid peroxidation: their utility in evaluating oxidative stress and analysis","volume":"11","author":"Janicka","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0135","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archpsyc.1995.03950210050010","article-title":"Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients","volume":"52","author":"Jeste","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0140","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archpsyc.1982.04290040069010","article-title":"Tardive dyskinesia: prevalence and risk factors, 1959 to 1979","volume":"39","author":"Kane","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/jnp.17.2.227","article-title":"Oxidative stress during treatment with first- and second-generation antipsychotics","volume":"17","author":"Kropp","year":"2005","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/B978-0-12-381328-2.00011-0","article-title":"Animal models of tardive dyskinesia","volume":"98","author":"Kulkarni","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s13311-013-0234-1","article-title":"Animal models of Parkinson's disease: a gateway to therapeutics?","volume":"11","author":"Le","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/pcn.12270","article-title":"Tardive dyskinesia (syndrome): current concept and modern approaches to its management","volume":"69","author":"Lerner","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0170","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/15622970802481895","article-title":"Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug","volume":"10","author":"Li","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0175","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1007\/s00213-014-3582-6","article-title":"Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies","volume":"231","author":"Lister","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1517\/14728214.2015.1050376","article-title":"Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in phase II and phase III clinical trials","volume":"20","author":"Lockwood","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1399-5618.2012.01046.x","article-title":"Effects of alpha-lipoic acid in an animal model of mania induced by d-amphetamine","volume":"14","author":"Macedo","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03033368","article-title":"Antipsychotic-induced oxidative stress in rat brain","volume":"13","author":"Martins","year":"2008","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/11632030-000000000-00000","article-title":"Off-label use of atypical antipsychotics: cause for concern?","volume":"26","author":"McKean","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0200","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1096\/fj.04-2330rev","article-title":"Isoprostanes: markers and mediators of oxidative stress","volume":"18","author":"Montuschi","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(97)00001-5","article-title":"The isoprostanes: unique bioactive products of lipid peroxidation","volume":"36","author":"Morrow","year":"1997","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0891-5849(95)00017-R","article-title":"Alpha-lipoic acid as a biological antioxidant","volume":"19","author":"Packer","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0891-5849(96)00269-9","article-title":"Neuroprotection by the metabolic antioxidant alpha-lipoic acid","volume":"22","author":"Packer","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neures.2011.01.004","article-title":"Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells","volume":"69","author":"Park","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0225","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1124\/jpet.113.207209","article-title":"Nonhuman primates: translational models for predicting antipsychotic-induced movement disorders","volume":"347","author":"Porsolt","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0230","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2165\/11592020-000000000-00000","article-title":"Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Pringsheim","year":"2011","journal-title":"Drug Saf."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0235","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2174\/13895575113136660100","article-title":"Haloperidol cytotoxicity and its relation to oxidative stress","volume":"13","author":"Raudenska","year":"2013","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/YCO.0b013e328017f6b1","article-title":"Tardive dyskinesia: eliminated, forgotten, or overshadowed?","volume":"20","author":"Remington","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pneurobio.2014.07.002","article-title":"Genetic animal models of dystonia: common features and diversities","volume":"121","author":"Richter","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0250","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0006-3223(99)00091-8","article-title":"The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia","volume":"46","author":"Sachdev","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb9000","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s002130050115","article-title":"Autoradiographic mapping of mu opioid receptor changes in rat brain after long-term haloperidol treatment: relationship to the development of vacuous chewing movements","volume":"128","author":"Sasaki","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0255","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/iub.40","article-title":"Is \u03b1-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity","volume":"60","author":"Shay","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tox.2005.01.003","article-title":"Brain regional responses in antioxidant system to alpha-lipoic acid in arsenic intoxicated rat","volume":"210","author":"Shila","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0265","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0022-3565(25)38260-1","article-title":"Oxidative stress and thiol modification induced by chronic administration of haloperidol","volume":"265","author":"Shivakumar","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000209.pub2","article-title":"Vitamin E for neuroleptic-induced tardive dyskinesia","author":"Soares-Weiser","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0275","first-page":"9","article-title":"Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011","volume":"9","author":"Stephenson","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0280","series-title":"Handbook of Clinical Neurology: Hyperkinetic Movement Disorders","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-444-52014-2.00043-4","article-title":"Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs","author":"Tarsy","year":"2011"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0285","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00702-009-0232-y","article-title":"Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats","volume":"116","author":"Thaakur","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0290","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","article-title":"The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?","volume":"26","author":"Turrone","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0295","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1300233","article-title":"Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats","volume":"28","author":"Turrone","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0300","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00213-002-1259-z","article-title":"The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats","volume":"165","author":"Turrone","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-381328-2.00008-0","article-title":"Tardive dyskinesia: clinical presentation and treatment","volume":"98","author":"van Harten","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0310","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.6132447","article-title":"Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6months of neuroleptic treatment","volume":"220","author":"Waddington","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2016.08.010_bb0315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.redox.2014.12.011","article-title":"Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria","volume":"4","author":"Zhong","year":"2015","journal-title":"Redox Biol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616301579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616301579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T14:20:09Z","timestamp":1749565209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584616301579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":64,"alternative-id":["S0278584616301579"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2016.08.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}